Search research articles
Contact Us
Filters
Showing results (101-110 of 195) with videos related to
Page
of 20
Sort By:
Acta Psychiatrica Scandinavica
|
April 1, 1983
Naloxone treatment for five days ineffective in schizophrenia. Neuroendocrine actions of the opiate antagonist
D Naber, U Münch, J Wissmann, et al.
Schizophrenia Research
|
April 11, 2001
Negative priming in schizophrenia: effects of masking and prime presentation time
S Moritz, C Ruff, U Wilke, et al.
Comprehensive Psychiatry
|
May 12, 2001
Subjective cognitive dysfunction in first-episode and chronic schizophrenic patients
S Moritz, M Lambert, B Andresen, et al.
Pharmacopsychiatry
|
March 29, 2012
Long-term efficacy and safety of asenapine or olanzapine in patients with schizophrenia or schizoaffective disorder: an extension study
J Schoemaker, L Stet, P Vrijland, et al.
Comprehensive Psychiatry
|
March 1, 1988
Personality variables, neurological and psychopathological symptoms in patients suffering from spasmodic torticollis
D Naber, D R Weinberger, M Bullinger, et al.
Der Nervenarzt
|
April 1, 1986
[Spasmodic torticollis. A study of symptoms, course, family history and psychopathology]
D Naber, D R Weinberger, M Bullinger, et al.
Lancet (London, England)
|
May 7, 1983
Serum cortisol correlates with depression score after open-heart surgery
D Naber, P Schmidt-Habelmann, M Bullinger, et al.
Psychopharmacology
|
October 1, 1995
An open trial of the D1 antagonist SCH 39166 in six cases of acute psychotic states
R de Beaurepaire, A Labelle, D Naber, et al.
Fortschritte Der Medizin
|
May 10, 1991
[Azidothymidine and the nervous system]
R R Riedel, L Bader, L Gürtler, et al.
Biological Psychiatry
|
September 1, 1981
Seasonal variations in the endogenous rhythm of dopamine receptor binding in rat striatum
D Naber, A Wirz-Justice, M S Kafka, et al.
Page
of 20
Search research articles
Search
Showing results (101-110 of 195) with videos related to
Sort By:
Page
of 20
Acta Psychiatrica Scandinavica
|
April 1, 1983
Naloxone treatment for five days ineffective in schizophrenia. Neuroendocrine actions of the opiate antagonist
D Naber, U Münch, J Wissmann, et al.
Schizophrenia Research
|
April 11, 2001
Negative priming in schizophrenia: effects of masking and prime presentation time
S Moritz, C Ruff, U Wilke, et al.
Comprehensive Psychiatry
|
May 12, 2001
Subjective cognitive dysfunction in first-episode and chronic schizophrenic patients
S Moritz, M Lambert, B Andresen, et al.
Pharmacopsychiatry
|
March 29, 2012
Long-term efficacy and safety of asenapine or olanzapine in patients with schizophrenia or schizoaffective disorder: an extension study
J Schoemaker, L Stet, P Vrijland, et al.
Comprehensive Psychiatry
|
March 1, 1988
Personality variables, neurological and psychopathological symptoms in patients suffering from spasmodic torticollis
D Naber, D R Weinberger, M Bullinger, et al.
Der Nervenarzt
|
April 1, 1986
[Spasmodic torticollis. A study of symptoms, course, family history and psychopathology]
D Naber, D R Weinberger, M Bullinger, et al.
Lancet (London, England)
|
May 7, 1983
Serum cortisol correlates with depression score after open-heart surgery
D Naber, P Schmidt-Habelmann, M Bullinger, et al.
Psychopharmacology
|
October 1, 1995
An open trial of the D1 antagonist SCH 39166 in six cases of acute psychotic states
R de Beaurepaire, A Labelle, D Naber, et al.
Fortschritte Der Medizin
|
May 10, 1991
[Azidothymidine and the nervous system]
R R Riedel, L Bader, L Gürtler, et al.
Biological Psychiatry
|
September 1, 1981
Seasonal variations in the endogenous rhythm of dopamine receptor binding in rat striatum
D Naber, A Wirz-Justice, M S Kafka, et al.
Page
of 20